May 13, 2022

MMJ Manufacturing Cannabis Soft Gelatin Capsules For Multiple Sclerosis, Huntington’s Disease Therapies

MMJ International Holdings Manufacturing Cannabis-based Investigational Therapies for MS, Huntington’s
January 1, 2020

x

WHY MMJ CANNNABIS RESEARCH AND CLINICAL TRIALS ARE NEEDED
January 1, 2020

x

WHY MMJ CANNNABIS RESEARCH AND CLINICAL TRIALS ARE NEEDED
January 1, 2020

cache

Terms and Condition
May 21, 2019

Marijuana Liquid Gel Medication in Production

The medical sciences research company, MMJ International Holdings, based in the United States and Jamaica, has reached an agreement with a specialty pharmaceutical company to manufacture […]
May 14, 2019

MMJ International Holdings Following FDA Guidance in Cannabis Drug Development Process

ST. PETERSBURG, FL / ACCESSWIRE / May 10, 2019 / MMJ International Holdings, the premier medical cannabis research company, recently announced that the FDA has made […]
February 28, 2019

Ed Begley’s Jr TV Innovation Series Interviews MMJ International Holdings Marijuana Science Team

Ed Begley’s Jr TV Innovation Series Interviews MMJ International Holdings Marijuana Science Team Creating Awareness About the Science of Medical Marijuana MMJ is all about helping […]
November 14, 2018

MMJ International Holdings Files FDA Orphan Drug Application for Huntington’s Disease

MMJ International Holdings, the premier medical cannabis research company, announced that is has filed an application with the FDA for “Orphan Drug Designation” for its drug […]
August 3, 2018

MMJ International Holdings Files FDA Application for Huntington’s Disease for Pharmaceutical Cannabis Medicine Study Approval

RESTON, VA / ACCESSWIRE / August 3, 2018 / MMJ International Holdings, the premier medical sciences research company that is currently advancing the science of medical […]
//]]>